CTSB can cleave α - ENaC and activate ENaC in situ, or it may increase the activity of ENaC by acting on proteins known to regulate the insertion, gating, recycling, or degradation of ENaC, thereby promoting hypertension in patients with nephrotic syndrome (42–44). Here, CTSB is linked to hypertensive disorder.